• Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Rescue of adult hippocampal neurogenesis in a mouse model of HIV neurologic disease.

The prevalence of central nervous system (CNS) neurologic dysfunction associated with human immunodeficiency virus (HIV) infection continues to increase, despite the use of antiretroviral therapy. Previous work has focused on the deleterious effects of HIV on mature neurons and on development of neuroprotective strategies, which have consistently failed to show a meaningful clinical benefit. It is now well established that new neurons are continuously generated in discrete regions in the adult mammalian brain, and accumulating evidence supports important roles for these neurons in specific cognitive functions. In a transgenic mouse model of HIV neurologic disease with glial expression of the HIV envelope protein gp120, we demonstrate a significant reduction in proliferation of hippocampal neural progenitors in the dentate gyrus of adult animals, resulting in a dramatic decrease in the number of newborn neurons in the adult brain. We identify amplifying neural progenitor cells (ANPs) as the first class of progenitors affected by gp120, and we also demonstrate that newly generated neurons exhibit aberrant dendritic development. Furthermore, voluntary exercise and treatment with a selective serotonin reuptake inhibitor increase the ANP population and rescue the observed deficits in gp120 transgenic mice. Thus, during HIV infection, the envelope protein gp120 may potently inhibit adult hippocampal neurogenesis, and neurorestorative approaches may be effective in ameliorating these effects. Our study has significant implications for the development of novel therapeutic approaches for HIV-infected individuals with neurologic dysfunction and may be applicable to other neurodegenerative diseases in which hippocampal neurogenesis is impaired.

Pubmed ID: 21146610

Authors

  • Lee MH
  • Wang T
  • Jang MH
  • Steiner J
  • Haughey N
  • Ming GL
  • Song H
  • Nath A
  • Venkatesan A

Journal

Neurobiology of disease

Publication Data

March 31, 2011

Associated Grants

  • Agency: NIA NIH HHS, Id: AG024984
  • Agency: NIDA NIH HHS, Id: K08 DA022946
  • Agency: NIDA NIH HHS, Id: K08 DA022946-01
  • Agency: NIDA NIH HHS, Id: K08DA022946
  • Agency: NINDS NIH HHS, Id: NS047344
  • Agency: NINDS NIH HHS, Id: NS048271
  • Agency: NIMH NIH HHS, Id: P30 MH075673
  • Agency: NIMH NIH HHS, Id: P30MH075673
  • Agency: NIDA NIH HHS, Id: R01 DA024593
  • Agency: NIDA NIH HHS, Id: R01DA024593
  • Agency: NINDS NIH HHS, Id: R01NS039253
  • Agency: NIMH NIH HHS, Id: R21 MH072534

Mesh Terms

  • Age Factors
  • Animals
  • Cells, Cultured
  • Disease Models, Animal
  • Embryonic Stem Cells
  • HIV Envelope Protein gp120
  • HIV Infections
  • Hippocampus
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Neurogenesis
  • Physical Conditioning, Animal